Inside a lab that will open in a couple of months in Chicago, a biotech startup will soon begin perfecting the process of 3D-printing human hearts that could eventually be used in transplants.

"What this is set up to do is to make a patient-specific, fully functioning heart that's viable for transplant, using the patient's own cells," says Stephen Morris, founding partner and CEO of the startup, Biolife4D.